Park Avenue Securities’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
20,388
-4,947
| -20% | -$263K | 0.01% | 755 |
|
|
2025
Q1 | $1.1M | Buy |
25,335
+1,449
| +6% | +$62.7K | 0.01% | 589 |
|
|
2024
Q4 | $1.34M | Sell |
23,886
-1,431
| -6% | -$80.4K | 0.01% | 629 |
|
|
2024
Q3 | $1.73M | Sell |
25,317
-7,210
| -22% | -$491K | 0.02% | 477 |
|
|
2024
Q2 | $1.37M | Buy |
32,527
+4,127
| +15% | +$174K | 0.02% | 534 |
|
|
2024
Q1 | $1.96M | Buy |
28,400
+7,151
| +34% | +$494K | 0.03% | 420 |
|
|
2023
Q4 | $1.57M | Sell |
21,249
-2
| -0% | -$148 | 0.02% | 448 |
|
|
2023
Q3 | $1.45M | Sell |
21,251
-3,015
| -12% | -$206K | 0.02% | 430 |
|
|
2023
Q2 | $2.28M | Sell |
24,266
-1,480
| -6% | -$139K | 0.04% | 292 |
|
|
2023
Q1 | $1.75M | Sell |
25,746
-3,722
| -13% | -$252K | 0.03% | 321 |
|
|
2022
Q4 | $1.46M | Buy |
29,468
+3,821
| +15% | +$189K | 0.03% | 383 |
|
|
2022
Q3 | $833K | Sell |
25,647
-2,051
| -7% | -$66.6K | 0.02% | 529 |
|
|
2022
Q2 | $1.09M | Buy |
27,698
+2,244
| +9% | +$88.4K | 0.02% | 426 |
|
|
2022
Q1 | $1.78M | Buy |
25,454
+7,081
| +39% | +$495K | 0.03% | 310 |
|
|
2021
Q4 | $1.43M | Buy |
18,373
+1,823
| +11% | +$142K | 0.03% | 348 |
|
|
2021
Q3 | $1.58M | Buy |
16,550
+1,752
| +12% | +$167K | 0.03% | 288 |
|
|
2021
Q2 | $1.84M | Buy |
14,798
+3,144
| +27% | +$391K | 0.04% | 242 |
|
|
2021
Q1 | $1.54M | Buy |
11,654
+5,213
| +81% | +$687K | 0.04% | 244 |
|
|
2020
Q4 | $853K | Buy |
6,441
+3,832
| +147% | +$507K | 0.02% | 328 |
|
|
2020
Q3 | $266K | Buy |
+2,609
| New | +$266K | 0.01% | 619 |
|